Global Cell & Gene Therapy Manufacturing Services Market Trends: Regional Breakdowns and Strategic Insights
Discover trends, market shifts, and competitive outlooks for the cell & gene therapy manufacturing services industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Has the Cell & Gene Therapy Manufacturing Services Market Growth Performance Trended Historically, And What Lies Ahead?
In recent years, there has been significant growth in the cell & gene therapy manufacturing services market. Its size is projected to expand from $8.15 billion in 2024 to $9.46 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.1%. Factors contributing to this growth during the historic period include augmented R&D investments, supportive regulatory frameworks, an expanding pipeline of cell & gene therapies, industry collaborations and partnerships, as well as a rising global demand for personalized medicine.
The manufacturing services market for cell and gene therapy is predicted to experience a significant surge in the forthcoming years. By 2029, the market will expand to “$17.97 billion, with an annual compound growth rate (CAGR) of 17.4%. Factors such as market maturation and commercialization, the worldwide growth of biopharmaceutical manufacturing, increased outsourcing by pharmaceutical firms, improvements in automation and robotics, and the rise of new therapeutic modalities contribute to the growth in the forecast period. Key trends for the forecast period involve growing demand for energy efficiency, innovation in materials and technologies, compact and modular design, electrification of transportation, alongside an emphasis on safety and reliability.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Cell & Gene Therapy Manufacturing Services Market?
The escalating prevalence of cancer and other related diseases is projected to accelerate the expansion of the cell and gene therapy manufacturing services market. Cancer is a grave ailment characterized by rapid and unregulated multiplication of the body’s cells, leading to abnormal growth. Innovations in cell and gene therapies are showing great promise to counter the surge in cancer occurrences and thus, creating the need for new and effective treatment options. An illustration of this can be seen in January 2023 when the American Cancer Society, a US-based nonprofit cancer advocacy organization, reported that the number of cancer cases soared from 1,898,160 in 2021 to 1,958,310 in 2023, marking a 3.16% increase. Consequently, the escalating prevalence of cancer and other related diseases serves as a catalyst for growth in the cell and gene therapy manufacturing services market.
Which Key Market Segments Comprise the Cell & Gene Therapy Manufacturing Services Market and Drive Its Revenue Growth?
The cell & gene therapy manufacturing services market covered in this report is segmented –
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=10035&type=smp
Which Areas Are Leading Regions in the Cell & Gene Therapy Manufacturing Services Market Expansion Across the Globe?
North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Strategic Trends Steering theCell & Gene Therapy Manufacturing Services Market Direction?
The rise in technological developments is a significant trend that is currently witnessing an increased traction in the cell and gene therapy manufacturing services market. Leading companies in this sector are leveraging these advanced technologies to maintain their market dominance. As an example, Charles River Laboratories International Inc., an American pharmaceutical firm with expertise in preclinical, clinical lab, gene therapy, and cell therapy services, rolled out a new product in October 2022. This product, named the Navigation Vector Platform, simplifies the Adeno-Associated Virus (AAV) vector manufacturing process to Good Manufacturing Practices (GMP) standards without demanding excessive process development. When compared to traditional manufacturing procedures, the Navigation platform can reduce the duration of a program leading to GMP by 55% for researchers involved in viral vector gene therapy. This inventive approach from Charles River is tailored to be scaled up and serotyped based on the needs of their clients and revolves around a distinct high productivity HEK293 suspension cell line.
View the full report here:
How Is the Cell & Gene Therapy Manufacturing Services Market Conceptually Defined?
Cell and gene therapy manufacturing services refer to the manufacturing and quality-testing services for gene and cell therapy products. It aids in the advancement and production of remedies for degenerative illnesses, tissue injuries, and genetic abnormalities. These services include good manufacturing practices ancillary reagents, flow cytometry, immunoassays, and gene engineering services.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10035
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
